Shenzhen Kexing Pharmaceutical Co., Ltd.

This early-stage trial tests a new drug called GB18 in 36 healthy adults to see if it is safe and how the body handles it. The drug is designed to treat cancer cachexia, a condition where cancer patients lose weight and muscle. Participants receive a single injection of GB18 or a…